Abstract
Thallium-201 has been shown to be useful in predicting tumour viability in patients undergoing neoadjuvant chemotherapy for osteogenic sarcoma. Early studies relied upon qualitative assessment of analog images to obtain predictive results. Recently, the lesion to normal tissue uptake ratio of201Tl has been used in evaluating bone and soft tissue sarcomas. This study attempts to quantitate changes in tumour to normal tissue ratio following chemotherapy. Eight consecutive patients with classical osteosarcoma received standard preoperative chemotherapy with a combination of cisplatin, adriamycin and high-dose methotrexate.201Tl gamma scintigraphic images were obtained both before and after chemotherapy. The average counts taken over the tumour divided by that from the contralateral normal tissue area yielded a tumour-to-normal tissue (T/N) ratio. The percentage change in the T/N ratio before and after preoperative chemotherapy was correlated with the percentage of tumour necrosis from pathological section. The median post-chemotherapy T/N ratio was 1.85 (range 0.5–7.7). The median percentage change in T/N ratio after chemotherapy was -58% (range +26% to -83%). The median percentage of necrosis from pathological section was 80% (range 0%–95%). There was a good correlation between the percentage of tumour necrosis and the percentage change in TIN ratio (rank correlation coefficientr=0.84,P=0.0085). Quantitative assessment of changes in 201+1 uptake by osteosarcoma correlates well with tumour necrosis after preoperative chemotherapy. This method may be used to predict response to chemotherapy at an earlier stage, enabling the clinician to consider alternative chemotherapeutic regimens or salvage surgery.
References
Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based upon the response of the primary tumour to preoperative chemotherapy.Cancer 1982; 49: 1221–1230.
Caluser I, Abdel-Dayem HM, Homer A, et al. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas.Eur J Nucl Med 1994; 21: 1198–1205
Ganz WI, Nguyen TQ, Benedetto MP, et al. Use of early, late and SPECT thallium imaging in evaluating activity of soft tissue and bone tumours [abstract].J Nucl Med 1993; 4: 32p
Ramanna L, Waxman AD, Waxman S, et al. Tl-201 (Tl) scintigraphy in bone and soft-tissue sarcoma: evaluation of tumour mass and viability.J Nucl Med 1988; 29: 854.
Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response.J Nucl Med 1990; 31: 567–572.
Rosen G, Loren GJ, Brien EW, et al. Serial thallium-201 scintigraphy in osteosarcoma: correlation with tumour necrosis after preoperative chemotherapy.Clin Orthop 1993; 293: 302–306.
Menendez LR, Fideler BM, Mirra J. Thallium-201 scanning for the evaluation of osteosarcoma and soft tissue sarcoma.J Bone Joint Surg [Am] 1993; 75: 526–531.
Rosen G, Marcove RC, Huvos AG, et al. Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy.J Cancer Res Clin Oncol 1983; 106: 55–67.
Caluser C, Macapinlac H, Healey J, et al. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumours.Clin Nucl Med 1992; 17: 565–571.
Sehweil AM, Mckillop JH, Milroy R, Wilson R, AbdelDayem HM, Omar YT. Mechanism of201Tl uptake in tumours.Eur J Nucl Med 1989; 15: 376–379.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lin, J., Leung, Wt., Ho, S.K.W. et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 22, 553–555 (1995). https://doi.org/10.1007/BF00817281
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00817281